Mr. Cullison takes the most pride in his work on KEYTRUDA and Gardasil, which is a vaccine used to prevent the HPV virus.
LAMBERTVILLE, NJ, February 15, 2023 /24-7PressRelease/ -- Mark Cullison has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Drawing on years of experience in marketing, management, and the pharmaceutical industry, Mr. Cullison presently excels as the managing director of CullCo Consulting and as head of U.S. specialty established brands for Teva Pharmaceuticals. In his executive role at Teva, he maintains responsibility for profits and losses in 20 product areas for the United States, including Bendeka, a treatment for oncology and hematology-related cancers, and Copaxone, which is the gold standard for treating multiple sclerosis. Previously, Mr. Cullison worked for Teva Pharmaceuticals as head of U.S. Migraine, head of U.S. specialty medicine marketing operations and legacy brands, and chief of staff to the head of specialty medicine.
During the early stages of his career, Mr. Cullison gained valuable expertise in pharmaceutical marketing and management with Bayer Pharmaceuticals and Merck, through which he worked on the cancer treatment, KEYTRUDA, which has been one of the highlights of his career. Outside of his work, he has contributed to his community through FACT Bucks County and New Hope Celebrates. Due to his outstanding breadth of knowledge, Mr. Cullison authored two publications, "Detection and Prevention of Foodborne Pathogens/Illness" and "Vaccination and the Empowerment in the Teaching of Pharmacists to Be Able to Help Vaccinate."
An expert in his field, Mr. Cullison holds a Bachelor of Science in microbiology, a Bachelor of Science in biochemistry, and a Master of Science in food science with a minor in epidemiology from North Carolina State University. Subsequently, he expanded upon his knowledge earning a Master of Public Health from Drexel University and several certifications through LinkedIn. In light of his professional accomplishments, Mr. Cullison won an award for helping North Carolina State University's Food Science Club raise money.
While his career has been filled with standout moments, Mr. Cullison takes the most pride in his work on KEYTRUDA and Gardasil, which is a vaccine used to prevent the HPV virus. The cornerstone of his success lay in his parents and maternal grandparents, who stressed the importance of an education and hard work. Within the next five years, Mr. Cullison intends to mentor the next generation of professionals in the industry and aid companies in meeting their business goals while also fostering his consultancy.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #